147 related articles for article (PubMed ID: 35577078)
1. Impact of Pulmonary Hypertension in Patients With Hypertrophic Cardiomyopathy Presented With Cardiogenic Shock/Acute Decompensated Heart Failure.
Chakraborty S; Das SK; Lorente-Ros M; Patel N; Hajra A; Bandyopadhyay D; Malik A; Goel A; Mukhopadhyay S; Aronow WS
Curr Probl Cardiol; 2022 Sep; 47(9):101251. PubMed ID: 35577078
[TBL] [Abstract][Full Text] [Related]
2. Comment on: Impact of Pulmonary Hypertension in Patients With Hypertrophic Cardiomyopathy Presented With Cardiogenic Shock/Acute Decompensated Heart Failure.
Turesh K; Tanisha ; Soojal ; Rajani D
Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102091. PubMed ID: 37734692
[No Abstract] [Full Text] [Related]
3. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
Hsu JC; Huang YT; Lin LY
Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample.
Thomas E; Yang J; Xu J; Lima FV; Stergiopoulos K
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066439
[TBL] [Abstract][Full Text] [Related]
5. Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation.
Choi YJ; Kim B; Rhee TM; Lee HJ; Lee H; Park JB; Lee SP; Han KD; Kim YJ; Kim HK
Sci Rep; 2022 Sep; 12(1):15785. PubMed ID: 36138115
[TBL] [Abstract][Full Text] [Related]
6. Cardiogenic Shock in Takotsubo Cardiomyopathy Versus Acute Myocardial Infarction: An 8-Year National Perspective on Clinical Characteristics, Management, and Outcomes.
Vallabhajosyula S; Dunlay SM; Murphree DH; Barsness GW; Sandhu GS; Lerman A; Prasad A
JACC Heart Fail; 2019 Jun; 7(6):469-476. PubMed ID: 31078481
[TBL] [Abstract][Full Text] [Related]
7. Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
Fauchier L; Bisson A; Bodin A; Herbert J; Spiesser P; Pierre B; Clementy N; Bernard A; Babuty D; Lip GYH
Stroke; 2022 Feb; 53(2):497-504. PubMed ID: 34601900
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy.
Ong KC; Geske JB; Hebl VB; Nishimura RA; Schaff HV; Ackerman MJ; Klarich KW; Siontis KC; Coutinho T; Dearani JA; Ommen SR; Gersh BJ
Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):604-10. PubMed ID: 26922089
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy.
Hamatani Y; Amaki M; Yonezawa R; Yanagi Y; Jo Y; Amano M; Okada A; Takahama H; Hasegawa T; Kanzaki H; Yasuda S; Izumi C
Int J Cardiovasc Imaging; 2019 May; 35(5):837-844. PubMed ID: 30623355
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.
Alphonse P; Virk S; Collins J; Campbell T; Thomas SP; Semsarian C; Kumar S
Clin Res Cardiol; 2021 Apr; 110(4):544-554. PubMed ID: 32880676
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Myocardial Bridging and Hypertrophic Cardiomyopathy and Their Implications on Percutaneous Coronary Intervention Outcomes: A Retrospective Study.
Alsughayer A; Alharbi A; Shah M; Cherian M; Vyas R; Assaly R
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102080. PubMed ID: 37722520
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with hypertrophic cardiomyopathy and acute myocardial infarction: a propensity score-matched, 15-year nationwide population-based study in Asia.
Wu VC; Chen TH; Wu M; Chen SW; Chang CH; Chang CW; Chen CC; Wu KP; Hsieh MJ; Wang CY; Chang SH; Lin FC; Hsieh IC; Chu PH; Wen MS
BMJ Open; 2018 Aug; 8(8):e019741. PubMed ID: 30139891
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of pulmonary hypertension on the outcomes of acute myocardial infarction patients with or without chronic obstructive pulmonary disease.
Oh S; Kim JH; Cho KH; Kim MC; Sim DS; Hong YJ; Ahn Y; Jeong MH
Medicine (Baltimore); 2022 Jan; 101(3):e28627. PubMed ID: 35060541
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy.
Musumeci MB; Mastromarino V; Casenghi M; Tini G; Francia P; Maruotti A; Romaniello A; Magrì D; Lillo R; Adduci C; Volpe M; Autore C
Int J Cardiol; 2017 Dec; 248():326-332. PubMed ID: 28733069
[TBL] [Abstract][Full Text] [Related]
17. Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy.
Sherrid MV; Swistel DG; Olivotto I; Pieroni M; Wever-Pinzon O; Riedy K; Bach RG; Husaini M; Cresci S; Reyentovich A; Massera D; Maron MS; Maron BJ; Kim B
J Am Heart Assoc; 2021 Oct; 10(20):e021141. PubMed ID: 34634917
[TBL] [Abstract][Full Text] [Related]
18. Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy.
Mekhaimar M; Al Mohannadi M; Dargham S; Al Suwaidi J; Jneid H; Abi Khalil C
Front Physiol; 2022; 13():976315. PubMed ID: 36439264
[No Abstract] [Full Text] [Related]
19. Frequency and Impact of Infectious Disease Conditions Diagnosed During Decompensated Heart Failure Hospitalizations in the United States.
Alvarez PA; Briasoulis A; Malik AH
Am J Cardiol; 2023 Mar; 191():1-7. PubMed ID: 36621054
[TBL] [Abstract][Full Text] [Related]
20. Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
Gharbin J; Winful A; Hassan MA; Bajaj S; Batta Y; Alebna P; Rhodd S; Taha M; Fatima U; Mehrotra P
Curr Probl Cardiol; 2023 May; 48(5):101609. PubMed ID: 36690309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
